INMB - Inmune Bio, Inc.
6.97
-0.120 -1.722%
Share volume: 238,240
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$7.09
-0.12
-0.02%
Summary score
6%
Profitability
2%
Dept financing
2%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-3.78%
Return on assets
-11.8%
Return on sales
0%
Return on invested capital
2.21%
Total debt ratio
13.66%
Debt ratio change over timeo
0%
Current Ratio
8.81%
Quick Ratio
0%
Cash Position Ratio
7.13%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-10.3%
Return on assets
-9.91%
Return on sales
0%
Return on invested capital
-15.08%
Total debt ratio
4.38%
Debt ratio change over timeo
0%
Current Ratio
9.85%
Quick Ratio
0%
Cash Position Ratio
8.39%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-9.72%
Return on assets
-9.14%
Return on sales
0%
Return on invested capital
-13.62%
Total debt ratio
5.91%
Debt ratio change over time
0%
Current Ratio
5.22%
Quick Ratio
0%
Cash Position Ratio
3.96%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INMB | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -3.78% | 11.55% | 5.76% | -13.17% |
| Return on assets | -11.8% | 3.57% | 4.02% | -8.16% |
| Return on sales | 0% | 42.16% | 39.53% | -204.65% |
| Return on invested capital | 2.21% | 7.99% | 5.61% | -53.4% |
| Profitability | 7% | 97% | 78% | 0% |
| Total debt ratio | 13.66% | 74.11% | 65.71% | 38.48% |
| Debt ratio change over time | 0% | 0% | 376.49% | 0% |
| Dept financing | 5% | 25% | 47% | 13% |
| Current Ratio | 9.85% | 2.02% | 2.86% | 3.17% |
| Quick Ratio | 0% | 1.71% | 2.76% | 3.11% |
| Cash Position Ratio | 8.39% | 0.76% | 2.25% | 2.96% |
| Liquididy | 50% | 37% | 38% | 43% |
| Short-term ratios | INMB | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -10.3% | 17.94% | -1.29% | -13.17% |
| Return on assets | -9.91% | 3.67% | 1.51% | -8.16% |
| Return on sales | 0% | 37.5% | 16.39% | -204.65% |
| Return on invested capital | -15.08% | 7.17% | -0.65% | -53.4% |
| Profitability | 0% | 100% | 21% | 0% |
| Total debt ratio | 4.38% | 83.42% | 64.86% | 38.48% |
| Debt ratio change over time | 0% | 0% | 1.76% | 0% |
| Dept financing | 1% | 25% | 44% | 12% |
| Current Ratio | 9.85% | 2.02% | 2.86% | 3.17% |
| Quick Ratio | 0% | 1.71% | 2.76% | 3.11% |
| Cash Position Ratio | 8.39% | 0.76% | 2.25% | 2.96% |
| Liquididy | 50% | 21% | 36% | 42% |
